With this historically low volume, I wonder what happens if a new investor decides to buy lets day a million shares and tries to accumulate prudently without spiking the price. If and when this happens, long time suffers, looking for a reasonable exit, will have a chance to move on.
The opportunity may be available in the next 4-5 weeks as earnings day approaches. Good to see LCI numbers on CNS sales.
Latest data is about $1.2 billion, down from $1.5 billion.
This much discussed potential CNS ANDA that he speaks of having a $1.5 B market (generic Concerta or something else) is based on September 2019 IQVIA numbers. With a CAGR at 8.5%, we can reasonably expect IQVIA to project this drug - whatever it might be - to be about $1.75 B market today.
According to IQVIA Health, the Concerta brand and generic products had US sales of around USD 1.159 billion for the most recent 12 months ending in June 2020.
not sure why there is any support dor this stock. i stay because it stand the thought of missing a run yet my better me says there's no way this POS moves